Predictive Validation and the Re-Analysis of Cost-Effectiveness: Do We Dare to Tread? [electronic resource]
- PharmacoEconomics 11 2017
- 1111-1112 p. digital
Publication Type: Editorial; Comment
1179-2027
10.1007/s40273-017-0561-x doi
Cost-Benefit Analysis Decision Making Models, Economic Uncertainty